PGEN

#2142
Precigen, Inc. - Common Stock
4.4 8 USD
-0.67%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
4.47
4.58
Rango anual
1.28
5.47
Cambio diario
-0.67%
Variación mensual
+9.54%
Variación en los últimos 6 meses
+16.36%
Cambio anual
+224.64%
Cierres anteriores
4.5 1
Open
4.4 9
Mínimo
4.4 7
High
4.5 8
Volumen
277
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.6 B
  • Employee 47
  • Founded 1998
  • CEO Helen Sabzevari
  • Website www.precigen.com
  • Headquarter Virginia, United States
  • FIGI BBG000QL8VH9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.05
Relación precio/flujo de caja
135.09

Precigen, Inc. - Common Stock

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

Noticias